Media Partners
The BioIndustry Association (BIA) is the trade association for innovative enterprises in the UK's bioscience sector. Established in 1989, our mission is to encourage and promote a thriving, financially sound sector of the UK economy, built upon developments across the biosciences.
We seek to create economic growth, increase employment opportunities, and expand the skills base. www.bioindustry.org
BioPharm Insight is the leading provider of intelligence to the biotechnology & pharmaceutical industry. We provide: detailed company profiles for over 4,400 biotech & pharmaceutical companies; listings on 36,000+ investigational & 23,000+ approved drugs; contact info for 250,000+ industry contacts (includes email & direct phone); 3,000+, easy-to-digest, licensing agreement synopses; product forecasts through 2018; and exclusive editorial intelligence. Our proprietary journalists cover the most important situations taking place in the life sciences industry. They tap leading CEOs, scientists, clinicians, lawyers, and other experts to provide forward looking insight into drug pipelines, upcoming litigation (including patent expirations), drug licensing deals, and mergers & acquisitions.
Current Medical Research & Opinion (CMRO) is a MEDLINE-indexed, peer-reviewed, international journal for the publication of original research on new and existing drugs and therapies, Phase II-IV studies, post-marketing investigations, and pharmacoeconomic and quality of life studies. With a 2010 Impact Factor of 2.609, and ranked in the top quartile of the Thomson Reuters ISI General & Internal Medicine category, the journal has a place in every major medical library collection. For more information, please visit www.cmrojournal.com or email info@cmrojournal.com.
EP Vantage is a daily comment and analysis service for the pharma and biotech industry, providing valuable forward-looking commentary on the events that will shape the future of the industry. EP Vantage's examination of pivotal sector events encompasses drug approvals, patent decisions, clinical trial results, and corporate activity. Global in reach EP Vantage puts into context the trends in the sector and how they can affect share price movements. Tailored to the needs of pharma executives and financial professionals, EP Vantage is a must read for anyone serious about the industry. In recognition of the quality of its analysis this year EP Vantage was named Commentator of the Year at the European Mediscience Awards.
For more information and to apply for a free trial visit www.epvantage.com
Eucomed represents the medical technology industry in Europe. Its mission is to make modern, innovative and reliable medical technology available to more people.
Eucomed members include both national and pan-European trade and product associations as well as medical technology manufacturers. In total Eucomed represents around 22,500 designers, manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and amelioration of disease and disability.
Eucomed promotes a balanced policy environment that enables the medical technology industry to meet the growing healthcare needs and expectations of its stakeholders. Eucomed maintains a close dialogue with its stakeholders and demonstrates the value of medical technology through health-economic research, data collection, membership services and clear communications.
For more information visit www.eucomed.org
The Expert Opinion journal portfolio provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. With 11 internationally peer-reviewed journals, we cover the full spectrum of drug development and application.
Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.
The distinctive Expert Opinion section within each review provides a personal commentary from the author on the most effective and promising strategies: an invaluable resource for decision-makers in the field.
For more information and to apply for a FREE 30 day Trial, visit www.expertopin.com or email expertopin@informa.com.
Journal of Medical Marketing is the leading international journal for executives performing a marketing or commercial role at every company producing pharmaceuticals, medical devices or diagnostic equipment for the medical industry.
Every quarter, the journal publishes a wide range of peer-reviewed practice papers, research articles and professional briefings written by industry experts. Articles focus on the issues of key importance to medical marketers.
Pharmaceutical Technology Europe (PTE) magazine is the market-leading publication for European professionals actively involved in pharmaceutical/biopharmaceutical development, manufacturing and QA/QC.
Serving the specialist information needs of European R&D and pharmaceutical process professionals, PTE's editorial focuses on new technologies, product developments, critical regulatory issues as well as practical solutions to increase the efficiency and productivity of drug development and production.
Every month 18,000 (BPA Audited) professionals depend on PTE to provide them with timely unbiased and essential information on the European pharmaceutical industry.
Professionals can subscribe FREE to the print magazine, digital digest and e-alerts.
Pharmaceutical Executive Global Digest is the leading strategy based business management publication for senior executives, corporate strategists and sales & marketing leaders in the global pharmaceutical industry. Pharmaceutical Executive Global Digest reaches over 68,000 readers on a bi-weekly basis in an easy to read digital format.
Tackling strategic business and marketing issues, Pharmaceutical Executive Global Digest provides complete high-quality analysis, opinion and industry news on critical trends and developments; sales and marketing strategies; corporate policy, management and branding; research and development; legislation; finance; new technologies.
Readers of Pharmaceutical Executive Global Digest include top C-suite pharmaceutical executives plus marketeers, contract organisations and management consultants, all with direct links to the pharmaceutical industry.
PharmaTimes Magazine was the first independent monthly magazine for the pharmaceutical, biotechnology and healthcare industries.
The PharmaTimes portfolio includes the well-respected monthly PharmaTimes Magazine; three news elert services including World, UK and Clinical news; business forums, where thought-leaders meet to discuss the issues of the day; and a unique series of awards that recognise, reward and celebrate excellence.
PharmaVentures is an international healthcare advisory group providing leadership in all aspects of deals and alliances, from strategy formulations to implementation.
The company occupies a special position in the global marketplace because of our track record of successful outcomes, resulting from our unique insight into the world of deal making, our internationally recognised analytical and valuation capabilities, our own proprietary deal making database PharmaDealsŪ, and our extensive business relationship network and our outstanding success in M&A transactions.
PharmiWeb.com is the leading jobs and news portal for the pharmaceutical, biotech and life sciences sector. Constantly updated with the latest events, features, news and thousands of jobs from all the leading employers in the sector. PharmiWeb.com is brought to you by innovative online publisher and e-business solutions provider, PharmiWeb Solutions.
SCRIPIntelligence is the leading source of pharmaceutical and biotech news, analysis and data, providing expert knowledge at your fingertips and giving you the power to revolutionise your commercial, strategic and analytical activity.
When your time is tight, SCRIPIntelligence is the essential way to keep up-to-date on everything from business & company news, research & development to policy & regulation and people movements.
SCRIPIntelligence offers 24-hour access to its global coverage of the industry with personalised daily alerts, breaking news alerts, downloadable newsletters, market data, briefings and reports.
Visit www.scripintelligence.com/freetrial/ft for your FREE trial to the information source you can trust.
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver high quality critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization.
Thomson Reuters can provide the knowledge, tools and expertise to help support your drug discovery and development activities, optimize your IP portfolio, identify licensing and partnering opportunities, deliver successful regulatory submissions, keep you in touch with the rapidly-changing pharmaceutical and chemical markets, and make informed, early decisions.
